bpc 157 recommended daily dose BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or MOTS-C Dosage Chart: Protocol Guide
Description
isoniazid increases B6 requirements

A blood test can show if you are low on B12

When a provider wants to support certain nutrient pathways or when B12 status is being evaluated, lipotropics may be discussed

By ensuring adequate levels of this essential nutrient, individuals can support healthy sleep patterns, improve energy levels, and promote better appetite control
